Immune-directed therapy for type 1 diabetes at the clinical level: the Immune Tolerance Network (ITN) experience
{{output}}
Reestablishing immune tolerance in type 1 diabetes (T1D), a chronic autoimmune disease, is a major goal. The Immune Tolerance Network (ITN) has initiated eight clinical trials of immunomodulatory therapies in recent-onset T1D over the past decade. Results have... ...
